Mechanisms to expedite pediatric clinical trial site activation: The DOSE trial experience

Fogel, 2018, Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: a review, Contemp. Clin. Trials Commun., 11, 156, 10.1016/j.conctc.2018.08.001 Krafcik, 2017, A single center analysis of factors influencing study start-up timeline in clinical trials, Future Sci. OA., 3, FSO223, 10.4155/fsoa-2017-0025 Schimanski, 2013, Streamline and improve study start-up, Appl. Clin. Trials., 22 Lai, 2021, Drivers of start-up delays in global randomized clinical trials, Ther. Innov. Regul. Sci., 55, 212, 10.1007/s43441-020-00207-2 Lamberti, 2018, Assessing study start-up practices, performance, and perceptions among sponsors and contract research organizations, Ther. Innov. Regul. Sci., 52, 572, 10.1177/2168479017751403 Lamberti, 2013, Benchmarking the study initiation process, Ther. Innov. Regul. Sci., 47, 101, 10.1177/2168479012469947 Cernik, 2021, Non-cancer clinical trials start-up metrics at an academic medical center: implications for advancing research, Contemp. Clin. Trials Commun., 22, 10.1016/j.conctc.2021.100774 National Institutes of Health National Center for Advancing Translational Sciences National Institutes of Health HEAL Initiative National Institutes of Health HEAL Initiative Eunice Kennedy Shriver National Institute of Child Health and Human Development Farfel, 2009 Goodlett, 2020, Site engagement for multi-site clinical trials, Contemp. Clin. Trials Commun., 19, 10.1016/j.conctc.2020.100608 Perez, 2016, Clinical trial electronic portals for expedited safety reporting: recommendations from the clinical trials transformation initiative investigational new drug safety advancement project, JMIR Cancer, 2, 10.2196/cancer.6701 The American Board of Pediatrics